These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 6024570)

  • 1. Detection of muscular dystrophy.
    N Engl J Med; 1967 Jun; 276(24):1379. PubMed ID: 6024570
    [No Abstract]   [Full Text] [Related]  

  • 2. Body-potassium concentation and rubidium metabolism determined by whole-body counting in Duchenne muscular dystrophy and its genetic carrier state.
    Nagai T; Sugita H; Iinuma TA; Furukawa T; Yashiro S
    J Nucl Med; 1969 Jan; 10(1):1-7. PubMed ID: 5797554
    [No Abstract]   [Full Text] [Related]  

  • 3. The value of determination of serum creatine phosphokinase activity in detection of carriers of progressive muscular dystrophy.
    Hetnarska L
    Pol Med J; 1968; 7(1):224-7. PubMed ID: 5650194
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tests of serum creatine phosphokinase activity in patients with progressive muscular dystrophy and their relatives for the detection of genetic carriers].
    László A; Salgó L
    Orv Hetil; 1981 Jun; 122(24):1453-6. PubMed ID: 7290660
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
    McCormick D; Allen IV
    Ulster Med J; 1976; 45(1):79-83. PubMed ID: 936362
    [No Abstract]   [Full Text] [Related]  

  • 6. Limb-girdle musclar dystrophy: its larger significance.
    Pediatrics; 1968 Feb; 41(2):382-4. PubMed ID: 5637790
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of carrier detection of Duchenne muscular dystrophy using carbonic anhydrase III and creatine kinase.
    Heath R; Carter ND; Jeffery S; Edwards RJ; Watts DC; Watts RL
    Am J Med Genet; 1985 Jun; 21(2):291-6. PubMed ID: 3925781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic counseling in Duchenne muscular dystrophy.
    Bradley WG; Kelemen J
    Muscle Nerve; 1979; 2(5):325-8. PubMed ID: 492208
    [No Abstract]   [Full Text] [Related]  

  • 9. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum pyruvate-kinase (PK) activity during pregnancy in potential carriers for Duchenne muscular dystrophy.
    Zatz M; Passos MR; Bortolini ER
    Am J Med Genet; 1983 May; 15(1):149-51. PubMed ID: 6859115
    [No Abstract]   [Full Text] [Related]  

  • 11. The detection of female carriers of pseudohypertrophic muscular dystrophy.
    Kakulas BA; Knight JO; Gubbay SS; Mastaglia FL
    Proc Aust Assoc Neurol; 1968; 5(3):545-51. PubMed ID: 5709982
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening for Duchenne muscular dystrophy.
    Roses AD; Nicholson GA; Roe CR
    Pediatrics; 1977 Aug; 60(2):248-51. PubMed ID: 887342
    [No Abstract]   [Full Text] [Related]  

  • 13. A nearest neighbour decision rule for EMG detection of carriers of Duchenne muscular dystrophy.
    Hausmanowa-Petrusewicz I; Wierzbicka M; Jozwik A; Szmidt-Salkowska E; Borkowska J
    Electromyogr Clin Neurophysiol; 1982; 22(6):445-57. PubMed ID: 7140630
    [No Abstract]   [Full Text] [Related]  

  • 14. [Genetics of muscular dystrophies].
    Harper PS
    Recenti Prog Med; 1977 May; 62(5):489-511. PubMed ID: 329369
    [No Abstract]   [Full Text] [Related]  

  • 15. [Children with progressive muscular dystrophy and mothers with aminoaciduria].
    Kato F; Tamagawa K
    Iryo; 1967 Jul; 21(7):835-41. PubMed ID: 5582478
    [No Abstract]   [Full Text] [Related]  

  • 16. Carrier detection in X-linked muscular dystrophy.
    Walton JN
    J Genet Hum; 1969 Oct; 17(3):497-510. PubMed ID: 5387424
    [No Abstract]   [Full Text] [Related]  

  • 17. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 18. Creatine-kinase and pyruvate-kinase activities in normal children: implications in Duchenne muscular dystrophy carrier detection.
    Passos MR; Gonzalez CH; Zatz M
    Am J Med Genet; 1985 Oct; 22(2):255-62. PubMed ID: 4050856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne's muscular dystrophy: carrier detection by muscle ultrasound.
    Rott HD; Mulz D
    J Genet Hum; 1983 Mar; 31(1):63-5. PubMed ID: 6619807
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serum enzyme activities in the families of patients with progressive muscular dystrophy].
    Tani J; Yano I; Masaki H; Fukuyama K; Saeki B
    Iryo; 1967 Jul; 21(7):848-53. PubMed ID: 5582480
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.